Alopecia

NEW ORLEANS — In this Healio video exclusive, Ronda S. Farah, MD, discusses the use of off-label oral minoxidil for hair growth in patients with alopecia.

NEW ORLEANS — In this Healio video exclusive, Ronda S. Farah, MD, discusses how reducing Janus kinase inhibitor dosages in patients with alopecia areata should be completed safely.

NEW ORLEANS — In this Healio video exclusive, Ronda S. Farah, MD, discusses exosomes — which are not approved by the FDA — as new treatment options for hair growth in patients with alopecia.

NEW ORLEANS — In this Healio video exclusive, Ronda S. Farah, MD, discusses her presentation from the frontal fibrosing alopecia session at the American Academy of Dermatology Annual Meeting.

Patients aged 12 years and older with alopecia areata exhibited positive efficacy rates and tolerability when treated with ritlecitinib over a 24-week period, according to a phase 2b-3 trial published in The Lancet.

Ivarmacitinib doses of 4 mg and 8 mg were effective and generally tolerated in the treatment of adults with moderate to severe alopecia areata, according to a phase 2 study.

NEW ORLEANS — In this Healio exclusive video, Brett King, MD, PhD, discusses data indicating that down titration of baricitinib after 52 weeks may not be the optimal treatment strategy for patients with alopecia areata.

NEW ORLEANS — In this Healio exclusive video, Brett King, MD, PhD, discusses results from the BRAVE-AA1 and BRAVE-AA2 phase 3 clinical trials of baricitinib for patients with alopecia areata.

Patients with androgenetic alopecia demonstrated improvements in hair follicle growth and density after treatment with topical melatonin, according to a study.

Methotrexate and low-dose prednisone combination outperformed methotrexate alone in patients with chronic and recalcitrant alopecia totalis and alopecia universalis, according to a study.